Verwijs Marinus 4
4 · Aerovate Therapeutics, Inc. · Filed Nov 3, 2022
Insider Transaction Report
Form 4
Verwijs Marinus
Senior Vice President, CMC
Transactions
- Sale
Common Stock
2022-11-02$18.89/sh−1,130$21,346→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022.
- [F2]Includes 1,130 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).